Skip to main content
H.R. 2554 119th Congress House

Lower Drug Costs for Families Act

Official title: To amend title XVIII of the Social Security Act to apply prescription drug inflation rebates to drugs furnished in the commercial market and to change the base year for rebate calculations.

Introduced: April 1, 2025 Introduced by: Steven Horsford Democratic · Nevada See on congress.gov
Health
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 1, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 1, 2025
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now April 1, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Plain-English summary Congressional Research Service

Lower Drug Costs for Families Act

This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance.

Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties.

The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).

 Related & companion bills 1
  • S 1186 Lower Drug Costs for Families Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 6

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

 Cosponsors 2
All 2 Democratic 1
D
Cherfilus-McCormick, Sheila
Florida · Apr 1, 2025
 D
Johnson, Henry C. "Hank"
Georgia · Apr 1, 2025
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2554: Lower Drug Costs for Families Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-2554/
MLA
"H.R. 2554: Lower Drug Costs for Families Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-2554/.
Bluebook (legal)
H.R. 2554, 119th Cong. (2026), https://openamerica.io/bill/119-HR-2554/.
Markdown link
[H.R. 2554: Lower Drug Costs for Families Act](https://openamerica.io/bill/119-HR-2554/)
Report a problem